Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

EnteroMedics Inc (NASDAQ:ETRM)

10.70
BATS BZX Real-Time Price
As of 10:38am ET
 -3.00 / -21.90%
Today’s Change
1.75
Today|||52-Week Range
132.30
+435.00%
Year-to-Date
Stock Market Roundup, Jan. 10: NVDA Self-Driving Cars, ETRM Soars
Jan 10 / Zacks.com - Paid Partner Content
This Small-Cap Rotation Is Unconvincing
Jan 10 / TheStreet.com - Paid Partner Content
Still Struggling to Put Money to Work
Jan 10 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close13.70
Today’s open12.62
Day’s range10.56 - 12.97
Volume36,735
Average volume (3 months)1,639,302
Market cap$32.7M
Dividend yield--
Data as of 10:38am ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+27.01%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales39.90
Price/Book0.38

Competitors

 Today’s
change
Today’s
% change
CYTXCytori Therapeutics ...-0.01-0.63%
DXRDaxor Corp+0.46+5.47%
MGCDMGC Diagnostics Corp0.000.00%
ATECAlphatec Holdings In...-0.01-0.25%
Data as of 10:12am ET, 01/17/2017

Financials

Last reporting dateNovember 10, 2016
EPS forecast (this quarter)-$34.65
Annual revenue (last year)$292.0K
Annual profit (last year)-$25.5M
Net profit margin-8,732.45%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Dan W. Gladney
Senior VP-Operations &
Business Development
Peter M. Delange
Corporate headquarters
St. Paul, Minnesota

Forecasts


Search for Jobs